Pharmacology, Toxicology and Pharmaceutical Science
Mithramycin
100%
Natural Product
100%
Lung Cancer
100%
Methyltransferase Inhibitor
100%
Tumor Suppressor Protein
87%
Malignant Neoplasm
50%
Neoplasm
37%
Tissue Inhibitor of Metalloproteinase 3
25%
DNA (Cytosine 5) Methyltransferase 1
25%
Cytosine
25%
Antitumor Activity
12%
Anticarcinogen
12%
Natural Products and Their Synthetic Derivatives
12%
Enzyme-Linked Immunosorbent Assay
12%
High-Throughput Screening
12%
Methyl Group
12%
Pharmacognosy
12%
Pharmaceutics
12%
Methyltransferase
12%
Messenger RNA
12%
Cytotoxic Agent
12%
Biochemistry, Genetics and Molecular Biology
Tumor Suppressor Gene
100%
Methyltransferase
100%
Epigenetics
57%
DNA Methylation
57%
DNMT1
28%
Methylation
28%
Demethylation
28%
Cancer Cell
28%
Promoter Region
28%
Metalloprotease Inhibitor
28%
CpG Island
28%
Cytosine
28%
Anticancer
28%
DNA Binding
14%
Enzyme
14%
Pharmacognosy
14%
Animal Model
14%
Cell Migration
14%
Exon
14%
High Throughput Screening
14%
Gene Inactivation
14%
Hope
14%
Antineoplastic Activity
14%
Genetics
14%
Messenger RNA
14%
Programmed Cell Death
14%